Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018277
Filing Date
2025-06-26
Accepted
2025-06-26 16:30:17
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 form4-06262025_040606.html 4  
1 form4-06262025_040606.xml 4 3998
  Complete submission text file 0001415889-25-018277.txt   5596
Mailing Address 2855 GAZELLE COURT C/O IONIS PHARMACEUTICALS, INC. CARLSBAD CA 92010
Business Address
HOUGEN ELIZABETH L (Reporting) CIK: 0001074773 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-42179 | Film No.: 251080811
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)